Return On Equity of Stoke Therapeutics, Inc. from 31 Dec 2018 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Stoke Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2018 to 30 Sep 2025.
  • Stoke Therapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2025 was 13%.
  • Stoke Therapeutics, Inc. annual Return On Equity for 2024 was -42%, a 26% increase from 2023.
  • Stoke Therapeutics, Inc. annual Return On Equity for 2023 was -57%, a 20% decline from 2022.
  • Stoke Therapeutics, Inc. annual Return On Equity for 2022 was -47%, a 36% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Stoke Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 13% +68% 01 Jul 2025 30 Sep 2025
Q2 2025 18% +76% 01 Apr 2025 30 Jun 2025
Q1 2025 19% +85% 01 Jan 2025 31 Mar 2025
Q4 2024 -42% +15% +26% 01 Oct 2024 31 Dec 2024
Q3 2024 -54% -0.16% -0.3% 01 Jul 2024 30 Sep 2024
Q2 2024 -58% -5% -9.3% 01 Apr 2024 30 Jun 2024
Q1 2024 -65% -18% -37% 01 Jan 2024 31 Mar 2024
Q4 2023 -57% -9.5% -20% 01 Oct 2023 31 Dec 2023
Q3 2023 -54% -9.2% -20% 01 Jul 2023 30 Sep 2023
Q2 2023 -53% -11% -26% 01 Apr 2023 30 Jun 2023
Q1 2023 -48% -8.4% -21% 01 Jan 2023 31 Mar 2023
Q4 2022 -47% -12% -36% 01 Oct 2022 31 Dec 2022
Q3 2022 -45% -16% -56% 01 Jul 2022 30 Sep 2022
Q2 2022 -42% -15% -57% 01 Apr 2022 30 Jun 2022
Q1 2022 -39% -15% -62% 01 Jan 2022 31 Mar 2022
Q4 2021 -35% -12% -50% 01 Oct 2021 31 Dec 2021
Q3 2021 -29% -6% -26% 01 Jul 2021 30 Sep 2021
Q2 2021 -27% -7.1% -36% 01 Apr 2021 30 Jun 2021
Q1 2021 -24% -7.8% -48% 01 Jan 2021 31 Mar 2021
Q4 2020 -23% -7.1% -44% 01 Oct 2020 31 Dec 2020
Q3 2020 -23% -7.4% -47% 01 Jul 2020 30 Sep 2020
Q2 2020 -20% -1.4% -7.4% 01 Apr 2020 30 Jun 2020
Q1 2020 -16% +12% +41% 01 Jan 2020 31 Mar 2020
Q4 2019 -16% +18% +53% 01 Oct 2019 31 Dec 2019
Q3 2019 -16% 01 Jul 2019 30 Sep 2019
Q2 2019 -18% 01 Apr 2019 30 Jun 2019
Q1 2019 -28% 01 Jan 2019 31 Mar 2019
Q4 2018 -34% 01 Oct 2018 31 Dec 2018

Stoke Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -42% +15% +26% 01 Jan 2024 31 Dec 2024
2023 -57% -9.5% -20% 01 Jan 2023 31 Dec 2023
2022 -47% -12% -36% 01 Jan 2022 31 Dec 2022
2021 -35% -12% -50% 01 Jan 2021 31 Dec 2021
2020 -23% -7.1% -44% 01 Jan 2020 31 Dec 2020
2019 -16% +18% +53% 01 Jan 2019 31 Dec 2019
2018 -34% 01 Jan 2018 31 Dec 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.